SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc. (NASDAQ:KITE) today announced that Arie Belldegrun, M.D., FACS, Chairman, President and Chief Executive Officer, will present at the 35th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2017 at 4:30 PM Pacific Time. The event will be held in San Francisco at the Westin St. Francis.
A live audio webcast of the presentation will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of the webcast will be available on the website for approximately 30 days.
About Kite PharmaKite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at http://www.twitter.com/kitepharma.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170104005222/en/
Christine CassianoSVP, Corporate Communications & Investor Relationsccassiano@kitepharma.comorGreg MannVP, Investor Relationsgmann@kitepharma.com
Source: Kite Pharma, Inc.
News Provided by Acquire Media
